CYGNUS DUAL: payments to doctors
Payments that named CYGNUS DUAL as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $207K
- Providers
- 1,732
- Transactions
- 3,374
- Average per transaction
- $61
The per-transaction average — $61 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,732 providers the average total is $120, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Organogenesis Inc. | $207,464 | 100.0% |